ACQUISITION ESTABLISHES A STRONG PRESENCE IN
THE AMERICAS
STARCHEM EXPECTS TO GENERATE $48 MILLION IN REVENUE IN FY2023
(All figures are in Canadian dollars unless otherwise stated
and are subject to change due to currency fluctuations)
TORONTO, Nov. 6, 2023
/CNW/ - Aimia Inc. (TSX: AIM) ("Aimia"), a holding company
focused on long-term global investments, has announced today that
its Bozzetto Group ("Bozzetto") subsidiary has signed a
definitive share purchase agreement to acquire 65% of StarChem S.A.
("StarChem") for $25
million(1), with a potential earn-out of
$12.5 million(1) based on
specific EBITDA targets to be met over the next two years.
The purchase price will be funded entirely from Bozzetto's existing
credit facility and Bozzetto's cash on hand. The executive
management team of StarChem, with whom Bozzetto has had a
successful customer relationship since 2013, will retain a
collective minority stake of 35%.
StarChem, headquartered in San Pedro Sula, Honduras, is a leading manufacturer of
specialty chemical solutions used primarily in preparation, dyeing,
and finishing processes by its large, multi-national textile
industry customers. Established in 2007, StarChem operates its own
production facility and also owns 100% of the Merril production
facility. Together, these facilities have a total installed
production capacity of approximately 20,000 Metric Tonnes (MT) per
year, with potential for expansion. StarChem is expected to
generate approximately $48
million(1),(2) in revenue for the fiscal year
ending December 31, 2023 and achieve
an EBITDA margin of approximately 12%(2). Honduras is one of the world's largest textile
markets, with a focus on cotton production for some of the largest
U.S. textile manufacturers, including Starchem customers such as
Fruit of the Loom, Hanes, and Gildan. Bozzetto's acquisition
of StarChem will expand its geographical presence and advance
Aimia's stated plan to enter the Americas through M&A.
Phil Mittleman, CEO of Aimia,
commented: "StarChem has a reputation for excellence, and we are
excited to add their highly specialized chemical manufacturing
processes to Bozzetto's portfolio. The synergies with Bozzetto are
significant and the combination opens up new global sales
opportunities for both companies throughout the Americas."
Roberto Curreri, CEO of Bozzetto,
commented: "StarChem will be a cornerstone in our company's premium
product lineup, solidifying our position as a leader in specialty
chemicals in Central America and
the U.S., and bringing a rich history and outstanding technical
expertise that aligns with our strategy to achieve a leading
position in the Americas. Moreover, integration will be seamless as
the two management teams have collaborated successfully for over a
decade, and are equally committed to delivering a high value
proposition to customers every day. Our ambition is to bring
our ESG-focused model into their existing markets while offering a
full range of products and capabilities to our rapidly expanding
customer base worldwide."
Mr. Mittleman added, "This acquisition further demonstrates the
value Aimia adds to our portfolio companies through strategic
oversight and access to capital. After 100 years of leadership in
the European and Asian markets, Bozzetto will now have an
established manufacturing operation in the Americas that will serve
as a platform for further growth. This transaction underscores
Bozzetto's commitment to becoming one of the world's leading
providers of chemical solutions. We are thrilled to announce this
combination, and we continue to evaluate and pursue other exciting
opportunities to grow this business further."
(1) Based on USD/CAD
of 1.3683 as at November 3, 2023.
|
(2) Based on Fiscal
2023 projections using nine months actuals and three months
forecast. Fiscal Year 2023 ends December 31, 2023.
|
About Aimia
Aimia Inc. (TSX: AIM) is a holding company that makes long-term
investments in private and public businesses through controlling or
minority stakes. We target companies with durable economic
advantages evidenced by a track record of substantial free cash
flow generation over complete business cycles, strong growth
prospects, and guided by strong, experienced management teams.
Headquartered in Toronto, Canada,
Aimia is positioned to invest in any sector, wherever a suitable
opportunity can be identified worldwide. In addition, we seek
investments that may efficiently utilize the Company's operating
and capital loss carry-forwards to further enhance stakeholder
value.
For more information about Aimia, visit www.aimia.com.
About StarChem
StarChem, headquartered in San Pedro Sula, Honduras, is a leading specialty chemical
solutions producer primarily involved in the preparation, dyeing,
and finishing processes within the textile industry. StarChem,
through its two production entities, Merril and StarChem Honduras,
both of which are located in the San Pedro Sula industrial park,
collectively boast an installed production capacity of
approximately 20,000 MT per
year. The Honduran textile landscape primarily revolves
around cotton, with a predominant focus on t-shirt production,
valuing between US$200-300
million. StarChem's core clientele comprises Honduran
operations of major U.S. textile mill multinationals such as Fruit
of the Loom, Hanes, and Gildan.
Forward-Looking
Statements
This press release contains statements that constitute
"forward-looking information" within the meaning of Canadian
securities laws ("forward-looking statements"), which are based
upon our current expectations, estimates, projections, assumptions
and beliefs. All information that is not clearly historical in
nature may constitute forward-looking statements. Forward-looking
statements are typically identified by the use of terms such
phrases such as "anticipate", "believe", "could", "estimate",
"expect", "intend", "may", "plan", "predict", "project", "will",
"would" and "should", and similar terms and phrases, including
references to assumptions.
Forward-looking statements in this press release include, but
are not limited to, statements with respect to the potential
earn-out; the timing of closing of the transaction; StarChem's
revenue and EBITDA margin for the fiscal year ending December 31, 2023; the new opportunities for
Bozzetto and StarChem; and Bozzetto's expansion in Mexico, San
Salvador, Guatemala and
other parts of North America.
Forward-looking statements, by their nature, are based on
assumptions and are subject to known and unknown risks and
uncertainties, both general and specific, that contribute to the
possibility that the forward-looking statement will not occur. The
forward-looking statements in this press release speak only as of
the date hereof and reflect several material factors, expectations
and assumptions. While Aimia considers these factors, expectations
and assumptions to be reasonable, actual events or results could
differ materially from the results, predictions, forecasts,
conclusions or projections expressed or implied in the
forward-looking statements. Undue reliance should not be placed on
any predictions or forward-looking statements as these may be
affected by, among other things, changing external events and
general uncertainties of the business. A discussion of the material
risks applicable to us can be found in our current Management
Discussion and Analysis and Annual Information Form, each of which
have been or will be filed on SEDAR+ and can be accessed at
www.sedarplus.ca. Aimia cautions that the list of risk factors
included in such Management Discussion and Analysis is not
exhaustive. Except as required by applicable securities laws,
forward-looking statements speak only as of the date on which they
are made and we disclaim any intention and assume no obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise.
Non-IFRS Measures
Reference to (i) "Adjusted EBITDA" is the unaudited pro forma
earnings of StarChem before interest, taxes, depreciation,
amortization as well as other income and financial expenses; and
(ii) "Adjusted EBITDA margins" is StarChem's Adjusted EBITDA
divided by its unaudited pro forma revenue. Adjusted EBITDA and
Adjusted EBITDA margins are non-standardized financial measures
that are not calculated or presented in accordance with
International Financial Reporting Standards ("IFRS"). Accordingly,
it may not be possible to compare StarChem's Adjusted EBITDA and
Adjusted EBITDA margins with Adjusted EBITDA and Adjusted EBITDA
margins or other financial measures of other companies having the
same or similar businesses.
In addition, all financial information regarding StarChem
contained in this press release has been derived from StarChem's
unaudited pro forma financial statements which are prepared in
accordance with Honduras Generally Accepted Accounting Principles
("Honduran GAAP"). Aimia prepares its financial statements in
accordance with IFRS. Honduran GAAP differs in certain respects
from IFRS.
SOURCE Aimia Inc.